The Southeast — Kentucky, Tennessee, Alabama and Mississippi — had a 25% higher dementia diagnosis rate compared to the ...

Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

With promising drugs in the pipeline, we are on the cusp of "turning the tide" against Alzheimer's. But President Trump's ...

The question is not if your family will face these challenges, but when they will face these challenges and whether you’ll be ...

With the United States population aging rapidly, advancing our understanding of age-related conditions that lead to cognitive ...